Khizar Rana
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Khizar Rana has a total of 85 co-authors. Here are the top co-authors by number of shared publications:
Dinesh Selva
Department of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, Adelaide, South Australia, 5000, Australia, adelaide.edu.au
20 shared publicationsSandy Patel
Department of Medical Imaging, Royal Adelaide Hospital, Adelaide, SA, Australia
15 shared publicationsValerie Juniat
Department of Ophthalmology and Visual Sciences, University of Adelaide, North Terrace, Australia
8 shared publicationsJames Slattery
Department of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, Adelaide, South Australia, 5000, Australia, adelaide.edu.au
7 shared publicationsWeng Onn Chan
University of Adelaide
6 shared publicationsCarmelo Caltabiano
Department of Ophthalmology & Visual Sciences, University of Adelaide, North Terrace, Adelaide, Australia
5 shared publications
Latest Publications
- Open Access
- 28 October 2026
- Published by Taylor & Francis in Ophthalmic Epidemiology
- p. 1-8
Glaucoma Treatment Trends in Australia Over a 10-Year Period
Glaucoma is a leading cause of irreversible blindness in Australia,1 affecting approximately 3% of people over 50 years, with prevalence expected to rise as the population ages.1 The primary manage...
- 28 October 2026
- Published by Taylor & Francis in Ophthalmic Epidemiology
- p. 1-8
Open AccessGlaucoma Treatment Trends in Australia Over a 10-Year Period
Glaucoma is a leading cause of irreversible blindness in Australia,1 affecting approximately 3% of people over 50 years, with prevalence expected to rise as the population ages.1 The primary manage...
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2026 (1)
Sulcus Placement of PreserFlo Microshunt in Iridocorneal Endothelial Syndrome: A Case Report
Background: Secondary angle‐closure glaucoma associated with iridocorneal endothelial (ICE) syndrome can be challenging to manage. This report presents a novel case of sulcus placement of a PreserFlo Microshunt in a patient with ICE syndrome following the failure of previous trabeculectomy and medical therapy. Case Presentation: A 61‐year‐old patient with secondary angle‐closure glaucoma due to ICE syndrome had uncontrolled intraocular pressures despite maximal medical therapy. They had a previous trabeculectomy, which failed following cataract surgery. Because of extensive peripheral anterior synechiae and risk of corneal decompensation, a PreserFlo Microshunt was placed in the sulcus. At the 18‐month postoperative follow‐up, intraocular pressure was well controlled without topical therapy. Conclusion: This is the first reported case of a PreserFlo Microshunt implanted in the sulcus in ICE syndrome. Sulcus placement provides a viable alternative in pseudophakic patients with extensive peripheral anterior synechiae, helping to mitigate the risk of corneal decompensation while effectively controlling intraocular pressure.
- 1 January 2026
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2026 (1)
Open AccessSulcus Placement of PreserFlo Microshunt in Iridocorneal Endothelial Syndrome: A Case Report
Background: Secondary angle‐closure glaucoma associated with iridocorneal endothelial (ICE) syndrome can be challenging to manage. This report presents a novel case of sulcus placement of a PreserFlo Microshunt in a patient with ICE syndrome following the failure of previous trabeculectomy and medical therapy. Case Presentation: A 61‐year‐old patient with secondary angle‐closure glaucoma due to ICE syndrome had uncontrolled intraocular pressures despite maximal medical therapy. They had a previous trabeculectomy, which failed following cataract surgery. Because of extensive peripheral anterior synechiae and risk of corneal decompensation, a PreserFlo Microshunt was placed in the sulcus. At the 18‐month postoperative follow‐up, intraocular pressure was well controlled without topical therapy. Conclusion: This is the first reported case of a PreserFlo Microshunt implanted in the sulcus in ICE syndrome. Sulcus placement provides a viable alternative in pseudophakic patients with extensive peripheral anterior synechiae, helping to mitigate the risk of corneal decompensation while effectively controlling intraocular pressure.
- Open Access
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Bilateral Idiopathic Dacryoadenitis in an Infant: A Case Report and Review of the Literature
Dacryoadenitis is most commonly caused by infectious, inflammatory or neoplastic processes. Idiopathic dacryoadenitis is exceptionally rare in children. We present a case of a 22‐month‐old previously healthy boy with progressive bilateral eyelid swelling, conjunctival chemosis and ocular discharge without systemic features. He was initially treated for atypical conjunctivitis but failed antimicrobial therapy and continued to deteriorate clinically. Investigations including bacterial swabs, viral serology and autoimmune testing were negative. Magnetic resonance imaging demonstrated bilateral lacrimal gland enlargement. Lacrimal gland biopsy revealed chronic lymphoplasmacytic inflammation without vasculitis or increased IgG4‐positive plasma cells. The patient was diagnosed with idiopathic dacryoadenitis and responded rapidly to systemic corticosteroids, with complete resolution within 3 weeks. This case highlights the diagnostic challenge of paediatric dacryoadenitis and the importance of early imaging and tissue diagnosis in atypical or progressive cases.
- 1 January 2026
- Published by Wiley in Case Reports in Pediatrics
- Vol. 2026 (1)
Open AccessBilateral Idiopathic Dacryoadenitis in an Infant: A Case Report and Review of the Literature
Dacryoadenitis is most commonly caused by infectious, inflammatory or neoplastic processes. Idiopathic dacryoadenitis is exceptionally rare in children. We present a case of a 22‐month‐old previously healthy boy with progressive bilateral eyelid swelling, conjunctival chemosis and ocular discharge without systemic features. He was initially treated for atypical conjunctivitis but failed antimicrobial therapy and continued to deteriorate clinically. Investigations including bacterial swabs, viral serology and autoimmune testing were negative. Magnetic resonance imaging demonstrated bilateral lacrimal gland enlargement. Lacrimal gland biopsy revealed chronic lymphoplasmacytic inflammation without vasculitis or increased IgG4‐positive plasma cells. The patient was diagnosed with idiopathic dacryoadenitis and responded rapidly to systemic corticosteroids, with complete resolution within 3 weeks. This case highlights the diagnostic challenge of paediatric dacryoadenitis and the importance of early imaging and tissue diagnosis in atypical or progressive cases.
- 11 December 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 30 (1) , 104724
Utility, safety, and accessibility of phone call follow-up in strabismus surgery postoperative care
- 11 December 2025
- Published by Elsevier in Journal of American Association for Pediatric Ophthalmology and Strabismus
- Vol. 30 (1) , 104724
Utility, safety, and accessibility of phone call follow-up in strabismus surgery postoperative care
- 5 December 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , 497-501
Orbital Nerve Enlargement: A Narrative Review
Purpose: This narrative review summarizes the causes of infraorbital and frontal nerve enlargement and their radiological features on magnetic resonance imaging and computed tomography. Methods: We conducted a systematic search of the literature, including PubMed, Ovid MEDLINE, EMBASE, Cochrane Library, and Google Scholar in May 2025. Studies were included if they reported a case of infraorbital and/or frontal nerve enlargement with magnetic resonance imaging or computed tomography correlation and specified the underlying etiology. This was supplemented by a series of cases to illustrate characteristic radiological features across pathologies. Results: Enlargement of the orbital nerves, particularly the infraorbital and frontal nerves, may be secondary to a range of underlying pathologies, including inflammatory, neoplastic, infectious, and traumatic diseases. Immunoglobulin G4-related ophthalmic disease is the most frequently reported cause and commonly presents with bilateral infraorbital nerve enlargement. Other causes include reactive lymphoid hyperplasia, lymphoma, schwannoma, traumatic neuroma, and perineural spread of malignancy. Infectious causes such as invasive aspergillosis and mucormycosis, and inflammatory conditions such as idiopathic granulomatous orbital inflammation and orbital inflammatory syndromes, have also been reported. This narrative review summarizes the causes of infraorbital and frontal nerve enlargement and their radiological features on magnetic resonance imaging and computed tomography. Conclusions: Infraorbital and frontal nerve enlargement, while uncommon, can arise from diverse etiologies. Infraorbital nerve enlargement is characteristic of immunoglobulin G4-related ophthalmic disease, particularly bilateral enlargement. Unilateral enlargement of any orbital nerve is most commonly due to primary nerve tumors or perineural spread of malignancy.
- 5 December 2025
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 42 (5) , 497-501
Orbital Nerve Enlargement: A Narrative Review
Purpose: This narrative review summarizes the causes of infraorbital and frontal nerve enlargement and their radiological features on magnetic resonance imaging and computed tomography. Methods: We conducted a systematic search of the literature, including PubMed, Ovid MEDLINE, EMBASE, Cochrane Library, and Google Scholar in May 2025. Studies were included if they reported a case of infraorbital and/or frontal nerve enlargement with magnetic resonance imaging or computed tomography correlation and specified the underlying etiology. This was supplemented by a series of cases to illustrate characteristic radiological features across pathologies. Results: Enlargement of the orbital nerves, particularly the infraorbital and frontal nerves, may be secondary to a range of underlying pathologies, including inflammatory, neoplastic, infectious, and traumatic diseases. Immunoglobulin G4-related ophthalmic disease is the most frequently reported cause and commonly presents with bilateral infraorbital nerve enlargement. Other causes include reactive lymphoid hyperplasia, lymphoma, schwannoma, traumatic neuroma, and perineural spread of malignancy. Infectious causes such as invasive aspergillosis and mucormycosis, and inflammatory conditions such as idiopathic granulomatous orbital inflammation and orbital inflammatory syndromes, have also been reported. This narrative review summarizes the causes of infraorbital and frontal nerve enlargement and their radiological features on magnetic resonance imaging and computed tomography. Conclusions: Infraorbital and frontal nerve enlargement, while uncommon, can arise from diverse etiologies. Infraorbital nerve enlargement is characteristic of immunoglobulin G4-related ophthalmic disease, particularly bilateral enlargement. Unilateral enlargement of any orbital nerve is most commonly due to primary nerve tumors or perineural spread of malignancy.
- Open Access
- 1 July 2025
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
- Vol. 39 (3) , 235-237
Asymmetric thyroid eye disease
PURPOSE: The purpose of this study was to evaluate asymmetric thyroid eye disease (TED) using an objective, radiological-based definition of asymmetry. METHODS: We conducted a retrospective study on TED patients with computed tomography (CT) orbits. Demographic, biochemical, and clinical presentation data were collected. Extraocular muscle volumes were determined by manually segmenting the muscles in consecutive slices. The extraocular muscle volumes were summed in the right and left orbits. Asymmetry was defined by a ratio of ≥1.4 between the total muscle volumes of both orbits. Unilateral disease was present if there was no muscle enlargement in the opposite orbit. Hertel exophthalmometry was performed on participants, and the difference between the right and left globe protrusion was compared. RESULTS: Fifteen out of 100 patients had asymmetric disease, of which 9 had unilateral disease. The mean age of participants was 55 ± 15 years, and 66 were female. No correlation was found between asymmetry and age, sex, thyroid status, or hormone levels. The exophthalmos difference was significantly greater in asymmetric orbits compared to nonasymmetric orbits. A cutoff of 2.75 mm for the exophthalmos difference gave a sensitivity of 0.87, specificity of 0.79, and an area under the curve of 0.83 for identifying radiologically defined asymmetric TED. CONCLUSION: There is currently no universally accepted definition for asymmetric TED. Current definitions rely on differences in clinical signs and symptoms between orbits which are unreliable. We present a cohort of asymmetric TED defined using an objective radiological marker of extraocular muscle volumes from CT scans.
- 1 July 2025
- Published by Wolters Kluwer Health in Saudi Journal of Ophthalmology
- Vol. 39 (3) , 235-237
Open AccessAsymmetric thyroid eye disease
PURPOSE: The purpose of this study was to evaluate asymmetric thyroid eye disease (TED) using an objective, radiological-based definition of asymmetry. METHODS: We conducted a retrospective study on TED patients with computed tomography (CT) orbits. Demographic, biochemical, and clinical presentation data were collected. Extraocular muscle volumes were determined by manually segmenting the muscles in consecutive slices. The extraocular muscle volumes were summed in the right and left orbits. Asymmetry was defined by a ratio of ≥1.4 between the total muscle volumes of both orbits. Unilateral disease was present if there was no muscle enlargement in the opposite orbit. Hertel exophthalmometry was performed on participants, and the difference between the right and left globe protrusion was compared. RESULTS: Fifteen out of 100 patients had asymmetric disease, of which 9 had unilateral disease. The mean age of participants was 55 ± 15 years, and 66 were female. No correlation was found between asymmetry and age, sex, thyroid status, or hormone levels. The exophthalmos difference was significantly greater in asymmetric orbits compared to nonasymmetric orbits. A cutoff of 2.75 mm for the exophthalmos difference gave a sensitivity of 0.87, specificity of 0.79, and an area under the curve of 0.83 for identifying radiologically defined asymmetric TED. CONCLUSION: There is currently no universally accepted definition for asymmetric TED. Current definitions rely on differences in clinical signs and symptoms between orbits which are unreliable. We present a cohort of asymmetric TED defined using an objective radiological marker of extraocular muscle volumes from CT scans.
- Open Access
- 27 February 2025
- Published by Taylor & Francis in Orbit
- Vol. 44 (5) , 504-510
Immunotherapy for orbital squamous cell carcinoma
To evaluate the demographics, clinical features and response of orbital squamous cell carcinoma treated with immunotherapy in an Australian and New Zealand cohort. This is a multi-institutional, retrospective case series. Data was collected on patient demographics, clinical presentation, imaging findings, treatment course and outcomes. Details of post-immunotherapy surgical interventions were documented along with their histological findings. Ten patients were included. All patients had invasive orbital squamous cell carcinoma. Perineural spread was present in six patients. Seven patients received Cemiplimab, while three patients received Pembrolizumab. No patients experienced side effects requiring cessation of immunotherapy. One patient died during follow up due to an unrelated cause. Eight (80%) patients had measurable radiological response, whereas one (10%) patient had progressive disease. Two patients had orbital exenteration: one due to progressive disease and one due to residual disease on MRI. One patient had orbital mapping biopsies. Two (66%) patients that had tissue analysis following immunotherapy showed complete pathologic response. Our findings support the emerging role of immunotherapy in the management of invasive orbital squamous cell carcinoma.
- 27 February 2025
- Published by Taylor & Francis in Orbit
- Vol. 44 (5) , 504-510
Open AccessImmunotherapy for orbital squamous cell carcinoma
To evaluate the demographics, clinical features and response of orbital squamous cell carcinoma treated with immunotherapy in an Australian and New Zealand cohort. This is a multi-institutional, retrospective case series. Data was collected on patient demographics, clinical presentation, imaging findings, treatment course and outcomes. Details of post-immunotherapy surgical interventions were documented along with their histological findings. Ten patients were included. All patients had invasive orbital squamous cell carcinoma. Perineural spread was present in six patients. Seven patients received Cemiplimab, while three patients received Pembrolizumab. No patients experienced side effects requiring cessation of immunotherapy. One patient died during follow up due to an unrelated cause. Eight (80%) patients had measurable radiological response, whereas one (10%) patient had progressive disease. Two patients had orbital exenteration: one due to progressive disease and one due to residual disease on MRI. One patient had orbital mapping biopsies. Two (66%) patients that had tissue analysis following immunotherapy showed complete pathologic response. Our findings support the emerging role of immunotherapy in the management of invasive orbital squamous cell carcinoma.
- Open Access
- 29 January 2025
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 47 (1) , 1-6
Normative measurements of the frontal nerve by magnetic resonance imaging in an Australia cohort
Purpose: To report the normative dimensions of the frontal nerve (FN) on fat-suppressed suppressed gadolinium (fs-gad) enhanced magnetic resonance imaging (MRI). Method: A retrospective cohort study of patients who underwent coronal fs-gad T1-weighted MRI. Orbits were excluded if there was unilateral or bilateral pathology of the FN or optic nerve sheath (ONS), incomplete MRI sequences, poor image quality or indiscernible FN on radiological assessment. The maximum diameter of the FN and ONS was measured. Results: The mean age of participants was 58 ± 16 years and 50% were females (n = 42). The mean normative measurements (mean ± standard deviation) on coronal T1-weighted imaging: optic nerve sheath, 5.08 ± 0.67mm. On coronal fs-gad T1-weighted imaging: frontal nerve, 0.74 ± 0.18mm. No significant differences were found between male or female participants in both the frontal nerve (p = 0.913) or optic nerve sheath (p = 0.646). There was no significant correlation between age and mean diameter of the frontal nerve (r = 0.14, p = 0.067) or optic nerve sheath (r = 0.075, p = 0.336). Additionally, no significant difference was identified between the mean diameter of the frontal nerve (p = 0.075) and optic nerve sheath (p = 0.120) across age groups. The mean frontal nerve to optic nerve sheath ratio was 0.15 ± 0.04. Conclusion: Normative dimensions of the FN may provide quantitative cut-offs that can aid the diagnosis of FN enlargement seen in instances such as IgG4-related ophthalmic disease (IgG4-ROD) and neoplastic perineural spread.
- 29 January 2025
- Published by Springer Nature in Surgical and Radiologic Anatomy
- Vol. 47 (1) , 1-6
Open AccessNormative measurements of the frontal nerve by magnetic resonance imaging in an Australia cohort
Purpose: To report the normative dimensions of the frontal nerve (FN) on fat-suppressed suppressed gadolinium (fs-gad) enhanced magnetic resonance imaging (MRI). Method: A retrospective cohort study of patients who underwent coronal fs-gad T1-weighted MRI. Orbits were excluded if there was unilateral or bilateral pathology of the FN or optic nerve sheath (ONS), incomplete MRI sequences, poor image quality or indiscernible FN on radiological assessment. The maximum diameter of the FN and ONS was measured. Results: The mean age of participants was 58 ± 16 years and 50% were females (n = 42). The mean normative measurements (mean ± standard deviation) on coronal T1-weighted imaging: optic nerve sheath, 5.08 ± 0.67mm. On coronal fs-gad T1-weighted imaging: frontal nerve, 0.74 ± 0.18mm. No significant differences were found between male or female participants in both the frontal nerve (p = 0.913) or optic nerve sheath (p = 0.646). There was no significant correlation between age and mean diameter of the frontal nerve (r = 0.14, p = 0.067) or optic nerve sheath (r = 0.075, p = 0.336). Additionally, no significant difference was identified between the mean diameter of the frontal nerve (p = 0.075) and optic nerve sheath (p = 0.120) across age groups. The mean frontal nerve to optic nerve sheath ratio was 0.15 ± 0.04. Conclusion: Normative dimensions of the FN may provide quantitative cut-offs that can aid the diagnosis of FN enlargement seen in instances such as IgG4-related ophthalmic disease (IgG4-ROD) and neoplastic perineural spread.
- Open Access
- 1 January 2025
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2025 (1) , 4822819
Herpes Zoster Ophthalmicus With Orbital Inflammation and Viral Meningitis in an Immunocompetent Patient
Common ocular manifestations of Herpes zoster ophthalmicus (HZO) include conjunctivitis, keratitis, anterior uveitis and ocular hypertension. Immunosuppressed patients are at an increased risk of sequelae including orbital inflammation and meningitis. We present a case of a 47‐year‐old immunocompetent patient who presented with acute orbital inflammation and viral meningitis, on a background of recent HZO without ocular involvement. Magnetic resonance imaging (MRI) demonstrated enhancement and enlargement of the left extraocular muscles, lacrimal gland and optic nerve sheath and enhancement of the left trigeminal nerve in the prepontine segment extending into the cavernous sinus. A lumbar puncture revealed elevated mononuclear cells consistent with viral meningitis. Cerebrospinal fluid polymerase chain reaction was negative for viruses. The patient was initially treated with intravenous acyclovir, which was followed by oral acyclovir. Oral prednisolone was commenced to treat the orbital inflammation. On 10‐week follow‐up, inflammatory signs had improved; however, the patient had persisting diplopia, which was managed with prismatic correction.
- 1 January 2025
- Published by Wiley in Case Reports in Ophthalmological Medicine
- Vol. 2025 (1) , 4822819
Open AccessHerpes Zoster Ophthalmicus With Orbital Inflammation and Viral Meningitis in an Immunocompetent Patient
Common ocular manifestations of Herpes zoster ophthalmicus (HZO) include conjunctivitis, keratitis, anterior uveitis and ocular hypertension. Immunosuppressed patients are at an increased risk of sequelae including orbital inflammation and meningitis. We present a case of a 47‐year‐old immunocompetent patient who presented with acute orbital inflammation and viral meningitis, on a background of recent HZO without ocular involvement. Magnetic resonance imaging (MRI) demonstrated enhancement and enlargement of the left extraocular muscles, lacrimal gland and optic nerve sheath and enhancement of the left trigeminal nerve in the prepontine segment extending into the cavernous sinus. A lumbar puncture revealed elevated mononuclear cells consistent with viral meningitis. Cerebrospinal fluid polymerase chain reaction was negative for viruses. The patient was initially treated with intravenous acyclovir, which was followed by oral acyclovir. Oral prednisolone was commenced to treat the orbital inflammation. On 10‐week follow‐up, inflammatory signs had improved; however, the patient had persisting diplopia, which was managed with prismatic correction.
- 24 December 2024
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 41 (5) , 504-515
Metastastic Tumors to the Lacrimal Gland from Distant Primary Cancer
Purpose: To characterize the clinical, radiological, and pathological features of patients with metastases to the lacrimal gland from distant primaries. Methods: Multicenter retrospective case series and a review of the literature of cases of metastases to the lacrimal gland. Results: The authors present 4 cases of lacrimal gland metastases, with the primaries being renal cell (n = 2) and breast (n = 2) carcinoma. The literature review identified 40 additional cases (19 male, mean age, range 21–84 years) of lacrimal gland metastasis. Based on these 44 cases, including 4 from the present study, 2 patterns of metastasis were identified: 23 cases (52.3%, 23/44) with lacrimal gland enlargement without bony erosion, and 21 cases (47.7%, 21/44) with associated bony erosion of the superolateral orbit of whom 12 (57.1%, 12/21) had intracranial extension. The most common primary for lacrimal gland metastasis without bony erosion was breast cancer (56.5%, 13/23), whereas hepatocellular carcinoma was the most common cause of lacrimal gland metastasis with bony erosion (52.4%, 11/21). Lacrimal gland metastasis was the first presentation of cancer in 15 cases (34.1%, 15/44) and was the first presentation of metastasis in 12 cases (27.3%, 12/44). Conclusions: Metastasis to the lacrimal gland is a potential cause of lacrimal gland enlargement. It may be the initial sign of distal occult cancer or occult metastatic disease. Different patterns of metastasis may be seen with different underlying primaries.
- 24 December 2024
- Published by Wolters Kluwer Health in Ophthalmic Plastic & Reconstructive Surgery
- Vol. 41 (5) , 504-515
Metastastic Tumors to the Lacrimal Gland from Distant Primary Cancer
Purpose: To characterize the clinical, radiological, and pathological features of patients with metastases to the lacrimal gland from distant primaries. Methods: Multicenter retrospective case series and a review of the literature of cases of metastases to the lacrimal gland. Results: The authors present 4 cases of lacrimal gland metastases, with the primaries being renal cell (n = 2) and breast (n = 2) carcinoma. The literature review identified 40 additional cases (19 male, mean age, range 21–84 years) of lacrimal gland metastasis. Based on these 44 cases, including 4 from the present study, 2 patterns of metastasis were identified: 23 cases (52.3%, 23/44) with lacrimal gland enlargement without bony erosion, and 21 cases (47.7%, 21/44) with associated bony erosion of the superolateral orbit of whom 12 (57.1%, 12/21) had intracranial extension. The most common primary for lacrimal gland metastasis without bony erosion was breast cancer (56.5%, 13/23), whereas hepatocellular carcinoma was the most common cause of lacrimal gland metastasis with bony erosion (52.4%, 11/21). Lacrimal gland metastasis was the first presentation of cancer in 15 cases (34.1%, 15/44) and was the first presentation of metastasis in 12 cases (27.3%, 12/44). Conclusions: Metastasis to the lacrimal gland is a potential cause of lacrimal gland enlargement. It may be the initial sign of distal occult cancer or occult metastatic disease. Different patterns of metastasis may be seen with different underlying primaries.